PMID: 26350340Sep 10, 2015Paper

Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis

CNS & Neurological Disorders Drug Targets
J A S CrippaA W Zuardi

Abstract

Since most patients with schizophrenia do not respond properly to treatment, scientific effort has been driven to the development of new compounds acting on pharmacological targets beyond the dopaminergic system. Therefore, the aim is to review basic and clinical research findings from studies evaluating the effects of cannabidiol (CBD), an inhibitor of the reuptake and metabolism of anandamide and several other effects on nervous system, and sodium nitroprusside, a nitric oxide donor, on the prevention and treatment of psychosis. Animal and human research supports that CBD and sodium nitroprusside might be effective in the prevention and treatment of psychosis in general and especially in schizophrenia. The evidence available to date shows that CBD and sodium nitroprusside act in pathways associated with psychotic symptoms and that they may be important agents in the management of prodromal psychotic states and psychosis. This underscores the relevance of further research on the effects of these agents and others that mediate the activity of the cannabinoid system and of nitric oxide, as well as comparative studies of their antipsychotic effects and those of other antipsychotic drugs currently used to treat schizophrenia.

Citations

Apr 3, 2018·Therapeutic Advances in Psychopharmacology·Paul D Morrison, Robin M Murray
Aug 15, 2019·Neurotoxicology·Stefania BonaccorsoFabrizio Schifano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
C D SchubartM P M Boks
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Marc W Manseau, Donald C Goff
© 2021 Meta ULC. All rights reserved